Patient-reported symptoms before palliative radiotherapy predict survival differences

[1]  M. Flentje,et al.  Patient-reported symptoms during radiotherapy , 2017, Strahlentherapie und Onkologie.

[2]  Liying Zhang,et al.  Impact of dyspnea on advanced cancer patients referred to a palliative radiotherapy clinic , 2017, Supportive Care in Cancer.

[3]  Y. Ejima,et al.  Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer , 2016, Strahlentherapie und Onkologie.

[4]  Shu-Yu Tai,et al.  Symptom severity of patients with advanced cancer in palliative care unit: longitudinal assessments of symptoms improvement , 2016, BMC Palliative Care.

[5]  V. Budach,et al.  Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer , 2015, Radiation Oncology.

[6]  S. Natsugoe,et al.  Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[7]  N. Kelekis,et al.  Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation , 2015, BioMed research international.

[8]  C. Takigawa,et al.  Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model. , 2015, European journal of cancer.

[9]  T. Agalioti,et al.  Pleural involvement in lung cancer. , 2015, Journal of thoracic disease.

[10]  C. Nieder,et al.  Colorectal cancer metastatic to the brain: analysis of prognostic factors and impact of KRAS mutations on presentation and outcome , 2015, Clinical and Translational Oncology.

[11]  C. Marijnen,et al.  An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases. , 2014, International journal of radiation oncology, biology, physics.

[12]  Carsten Nieder,et al.  Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy , 2014, ISRN oncology.

[13]  C. Nieder,et al.  Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy. , 2014, Anticancer research.

[14]  D. Rades,et al.  Breast cancer patients with metastatic spinal cord compression , 2014, Strahlentherapie und Onkologie.

[15]  Y. Toiyama,et al.  C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. , 2013, Anticancer research.

[16]  D. Rades,et al.  A simple survival score for patients with brain metastases from breast cancer , 2013, Strahlentherapie und Onkologie.

[17]  D. Rades,et al.  Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer , 2012, Strahlentherapie und Onkologie.

[18]  J. Nguyen,et al.  Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[19]  E. Bruera,et al.  Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study. , 2012, Journal of palliative medicine.

[20]  Meihua Wang,et al.  A nomogram for individualized estimation of survival among patients with brain metastasis. , 2012, Neuro-oncology.

[21]  L. Stalpers,et al.  Metastatic spinal cord compression in non-small cell lung cancer patients , 2012, Strahlentherapie und Onkologie.

[22]  Liying Zhang,et al.  Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System , 2012, Supportive Care in Cancer.

[23]  C. Earle,et al.  Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Liying Zhang,et al.  Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer. , 2011, Journal of palliative medicine.

[25]  R. Hong,et al.  Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma. , 2010, Oral oncology.

[26]  P. Brown,et al.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.

[27]  I. Tannock,et al.  Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. , 2009, International journal of radiation oncology, biology, physics.

[28]  E. Chow,et al.  Symptom clusters in patients with advanced-stage cancer referred for palliative radiation therapy in an outpatient setting. , 2007, Supportive cancer therapy.

[29]  F. Fang,et al.  Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy , 2004, Cancer.

[30]  W Curran,et al.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.

[31]  Eduardo Bruera,et al.  The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients , 1991, Journal of palliative care.

[32]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.